• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-MYC 介导乳腺癌细胞与肿瘤微环境之间的串扰。

c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment.

机构信息

Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.

出版信息

Cell Commun Signal. 2023 Jan 31;21(1):28. doi: 10.1186/s12964-023-01043-1.

DOI:10.1186/s12964-023-01043-1
PMID:36721232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9887805/
Abstract

The MYC oncogenic family is dysregulated in diverse tumors which is generally linked to the poor prognosis of tumors. The members in MYC family are transcription factors which are responsible for the regulation of various genes expression. Among them, c-MYC is closely related to the progression of tumors. Furthermore, c-MYC aberrations is tightly associated with the prevalence of breast cancer. Tumor microenvironment (TME) is composed of many different types of cellular and non-cellular factors, mainly including cancer-associated fibroblasts, tumor-associated macrophages, vascular endothelial cells, myeloid-derived suppressor cells and immune cells, all of which can affect the diagnosis, prognosis, and therapeutic efficacy of breast cancer. Importantly, the biological processes occurred in TME, such as angiogenesis, immune evasion, invasion, migration, and the recruition of stromal and tumor-infiltrating cells are under the modulation of c-MYC. These findings indicated that c-MYC serves as a critical regulator of TME. Here, we aimed to summarize and review the relevant research, thus to clarify c-MYC is a key mediator between breast cancer cells and TME. Video Abstract.

摘要

MYC 癌基因家族在多种肿瘤中失调,通常与肿瘤的预后不良有关。MYC 家族的成员是转录因子,负责调节各种基因的表达。其中,c-MYC 与肿瘤的进展密切相关。此外,c-MYC 异常与乳腺癌的高发密切相关。肿瘤微环境(TME)由许多不同类型的细胞和非细胞因素组成,主要包括癌相关成纤维细胞、肿瘤相关巨噬细胞、血管内皮细胞、髓源性抑制细胞和免疫细胞,它们都可以影响乳腺癌的诊断、预后和治疗效果。重要的是,TME 中发生的生物学过程,如血管生成、免疫逃逸、侵袭、迁移以及基质和肿瘤浸润细胞的募集,都受到 c-MYC 的调节。这些发现表明 c-MYC 是 TME 的关键调节因子。在这里,我们旨在总结和回顾相关研究,从而阐明 c-MYC 是乳腺癌细胞与 TME 之间的关键介质。视频摘要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/9887805/c66092f194b5/12964_2023_1043_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/9887805/c66092f194b5/12964_2023_1043_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbd/9887805/c66092f194b5/12964_2023_1043_Fig1_HTML.jpg

相似文献

1
c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment.c-MYC 介导乳腺癌细胞与肿瘤微环境之间的串扰。
Cell Commun Signal. 2023 Jan 31;21(1):28. doi: 10.1186/s12964-023-01043-1.
2
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis.MYC 作为肿瘤微环境中转移的多效调节因子
Int J Mol Sci. 2020 Oct 18;21(20):7710. doi: 10.3390/ijms21207710.
3
Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGFs/IGF-1R axis.c-Myc 表达的乳腺上皮细胞通过 IGFs/IGF-1R 轴旁分泌招募和激活成纤维细胞。
Int J Cancer. 2019 Nov 15;145(10):2827-2839. doi: 10.1002/ijc.32613. Epub 2019 Aug 23.
4
Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.人类乳腺癌肿瘤微环境,以及猫乳腺肿瘤作为潜在的研究模型。
Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188587. doi: 10.1016/j.bbcan.2021.188587. Epub 2021 Jul 5.
5
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.肿瘤微环境中癌症相关成纤维细胞与免疫细胞的串扰:新发现与未来展望。
Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1.
6
Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.肿瘤浸润免疫细胞与乳腺癌肿瘤生长和免疫抑制中的癌相关成纤维细胞之间的串扰。
J Immunol Res. 2021 Jul 13;2021:8840066. doi: 10.1155/2021/8840066. eCollection 2021.
7
Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression.肿瘤相关巨噬细胞的生物介质在乳腺癌进展中的作用
Curr Med Chem. 2022;29(33):5420-5440. doi: 10.2174/0929867329666220520121711.
8
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.在乳腺癌进展过程中肿瘤微环境中的细胞相互作用:新前沿及其对新型治疗的意义。
Front Immunol. 2024 Mar 12;15:1302587. doi: 10.3389/fimmu.2024.1302587. eCollection 2024.
9
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.肿瘤微环境作为乳腺癌干性和治疗抵抗的驱动因素:新的挑战和治疗机会。
Cell Oncol (Dordr). 2021 Dec;44(6):1209-1229. doi: 10.1007/s13402-021-00634-9. Epub 2021 Sep 16.
10
Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver.解析肿瘤微环境中肝星状细胞与癌细胞之间可能存在的相互循环。
Crit Rev Oncol Hematol. 2023 Feb;182:103902. doi: 10.1016/j.critrevonc.2022.103902. Epub 2023 Jan 5.

引用本文的文献

1
Plant-based synthesis of gold and silver nanoparticles using aqueous leaf extract and its anticancer activities.利用水相叶提取物进行金和银纳米颗粒的植物合成及其抗癌活性。
Narra J. 2025 Aug;5(2):e1770. doi: 10.52225/narra.v5i2.1770. Epub 2025 Apr 27.
2
Investigating the interaction of ACKR1 and c-Myc in the breast carcinoma tumor microenvironment modulation.研究ACKR1与c-Myc在乳腺癌肿瘤微环境调节中的相互作用。
Discov Oncol. 2025 Aug 25;16(1):1615. doi: 10.1007/s12672-025-03437-8.
3
The role of collagen type VI alpha 6 chain as a potential tumor suppressor in breast cancer: an immune regulation perspective.

本文引用的文献

1
MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer.MYC 通过转录上调三阴性乳腺癌中的 DNMT1 来抑制 STING 依赖性先天免疫。
J Immunother Cancer. 2021 Jul;9(7). doi: 10.1136/jitc-2021-002528.
2
Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth.肿瘤相关巨噬细胞作为乳腺肿瘤生长的多面调节因子
Int J Mol Sci. 2021 Jun 18;22(12):6526. doi: 10.3390/ijms22126526.
3
Poly-l-Lysine inhibits VEGF and c-Myc mediated tumor-angiogenesis and induces apoptosis in 2D and 3D tumor microenvironment of both MDA-MB-231 and B16F10 induced mice model.
VI型胶原蛋白α6链作为乳腺癌潜在肿瘤抑制因子的作用:免疫调节视角
BMC Cancer. 2025 Aug 23;25(1):1363. doi: 10.1186/s12885-025-14680-1.
4
Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy.增强低氧状态以将冷肿瘤转化为热肿瘤用于乳腺癌免疫治疗。
Cell Death Discov. 2025 Aug 14;11(1):381. doi: 10.1038/s41420-025-02682-8.
5
Single-Cell Sequence and Machine Learning Identify a CD79A+B Cells-Related Transcriptional Signature for Predicting Clinical Outcomes and Immune Microenvironment in Breast Cancer.单细胞测序与机器学习识别出一种与CD79A+B细胞相关的转录特征,用于预测乳腺癌的临床结局和免疫微环境。
Cancer Inform. 2025 Jul 26;24:11769351251360675. doi: 10.1177/11769351251360675. eCollection 2025.
6
Histone Acetyltransferase MOF-Mediated AURKB K215 Acetylation Drives Breast Cancer Cell Proliferation via c-MYC Stabilization.组蛋白乙酰转移酶MOF介导的AURKB K215乙酰化通过c-MYC稳定促进乳腺癌细胞增殖。
Cells. 2025 Jul 17;14(14):1100. doi: 10.3390/cells14141100.
7
Identification of dynamic network biomarker for erlotinib pre-resistance using single-cell differential covariance entropy.使用单细胞差分协方差熵鉴定厄洛替尼耐药前的动态网络生物标志物。
Mol Ther Oncol. 2025 May 15;33(2):200993. doi: 10.1016/j.omton.2025.200993. eCollection 2025 Jun 18.
8
Machine learning-based diagnostic and prognostic models for breast cancer: a new frontier on the clinical application of natural killer cell-related gene signatures in precision medicine.基于机器学习的乳腺癌诊断和预后模型:自然杀伤细胞相关基因特征在精准医学临床应用的新前沿。
Front Immunol. 2025 May 27;16:1581982. doi: 10.3389/fimmu.2025.1581982. eCollection 2025.
9
Molecular insights into immune evasion in head and neck squamous cell carcinomas: Toward a promising treatment strategy.头颈部鳞状细胞癌免疫逃逸的分子见解:迈向一种有前景的治疗策略。
Oncol Res. 2025 May 29;33(6):1271-1282. doi: 10.32604/or.2025.062207. eCollection 2025.
10
Modelling Cancer Pathophysiology: Mechanisms and Changes in the Extracellular Matrix During Cancer Initiation and Early Tumour Growth.癌症病理生理学建模:癌症起始和早期肿瘤生长过程中细胞外基质的机制与变化
Cancers (Basel). 2025 May 15;17(10):1675. doi: 10.3390/cancers17101675.
多聚-L-赖氨酸抑制 VEGF 和 c-Myc 介导的肿瘤血管生成,并在 MDA-MB-231 和 B16F10 诱导的小鼠模型的 2D 和 3D 肿瘤微环境中诱导细胞凋亡。
Int J Biol Macromol. 2021 Jul 31;183:528-548. doi: 10.1016/j.ijbiomac.2021.04.109. Epub 2021 Apr 21.
4
MYC as a target for cancer treatment.MYC 作为癌症治疗的靶点。
Cancer Treat Rev. 2021 Mar;94:102154. doi: 10.1016/j.ctrv.2021.102154. Epub 2021 Jan 19.
5
A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability.一种新型缺氧长链非编码RNA KB-1980E6.3通过与IGF2BP1相互作用以促进c-Myc mRNA稳定性来维持乳腺癌干细胞的干性。
Oncogene. 2021 Mar;40(9):1609-1627. doi: 10.1038/s41388-020-01638-9. Epub 2021 Jan 19.
6
MYC dysfunction modulates stemness and tumorigenesis in breast cancer.MYC 功能失调可调节乳腺癌中的干性和肿瘤发生。
Int J Biol Sci. 2021 Jan 1;17(1):178-187. doi: 10.7150/ijbs.51458. eCollection 2021.
7
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis.MYC 作为肿瘤微环境中转移的多效调节因子
Int J Mol Sci. 2020 Oct 18;21(20):7710. doi: 10.3390/ijms21207710.
8
The tumor microenvironment.肿瘤微环境。
Curr Biol. 2020 Aug 17;30(16):R921-R925. doi: 10.1016/j.cub.2020.06.081.
9
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.纳米治疗递送 c-myc 抑制剂靶向促肿瘤巨噬细胞并保留乳腺癌中的抗肿瘤巨噬细胞。
Theranostics. 2020 Jun 12;10(17):7510-7526. doi: 10.7150/thno.44523. eCollection 2020.
10
Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.成纤维细胞生长因子-2 来源于癌相关成纤维细胞,通过 FGFR1 信号通路刺激人乳腺癌细胞的生长和进展。
Mol Carcinog. 2020 Sep;59(9):1028-1040. doi: 10.1002/mc.23233. Epub 2020 Jun 18.